Hogge Gary S.
SEC CIK 1771711 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | SVP, Clinical, Medical Affairs | 13.0K | — | $1.32M | 4 | 2021-12-28 | 2023-02-11 |
Most active insiders at LCTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Culley Brian M | Pres, CEO, Dir | $24.4K | — |
| 2 | Samuel George A. III | GC, Sec | — | — |
Hogge Gary S. made no open-market trades at LCTX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP, Clinical, Medical Affairs | M - OptEx | — | +13.0K | 13.0K | New | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP, Clinical, Medical Affairs | F - Tax | $1.35 | -5,310 | 7,710 | -41% | -$7,169 |
| DM | 2021-12-30 | 2021-12-28+ | LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP, Clinical, Medical Affairs | M - OptEx | $1.42 | +510.8K | 530.0K | +2,661% | +$724.7K |
| DM | 2021-12-30 | 2021-12-28+ | LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP, Clinical, Medical Affairs | S - Sale+OE | $2.45 | -539.3K | 0 | -100% | -$1.32M |
Purchase Sale Sale after option exercise All abbreviations